Authors: Willem Benjamin Bruin; Leif Oltedal; Hauke Bartsch; Christopher Abbott; Miklos Argyelan; Tracy Barbour; Joan Camprodon; Samadrita Chowdhury; Randall Espinoza; Peter Mulders; Katherine Narr; Mardien Oudega; Didi Rhebergen; Freek ten Doesschate; Indira Tendolkar; Philip van Eijndhoven; Eric van Exel; Mike van Verseveld; Benjamin Wade; Jeroen van Waarde; Paul Zhutovsky; Annemiek Dols; Guido van Wingen · Research
Can Brain Scans Predict Who Will Benefit from Electroconvulsive Therapy for Depression?
A large international study finds brain scans may help predict which severely depressed patients will benefit from electroconvulsive therapy.
Source: Bruin, W. B., Oltedal, L., Bartsch, H., Abbott, C., Argyelan, M., Barbour, T., ... & van Wingen, G. (2024). Development and validation of a multimodal neuroimaging biomarker for electroconvulsive therapy outcome in depression: a multicenter machine learning analysis. Psychological Medicine, 54, 495-506. https://doi.org/10.1017/S0033291723002040
What you need to know
- Brain scans may help predict which severely depressed patients will benefit from electroconvulsive therapy (ECT)
- Combining brain structure and function data provided the best predictions of ECT outcomes
- Key brain regions involved include areas related to emotion regulation and self-reflection
- Larger studies are still needed before this approach could be used clinically
Using Brain Scans to Predict ECT Response
Electroconvulsive therapy (ECT) is considered the most effective treatment for severe, treatment-resistant depression. However, ECT is used in only 1-2% of patients with severe depression. This is partly because ECT requires anesthesia and can have side effects like temporary memory problems. It’s also relatively expensive, and it takes multiple sessions to determine if it’s working for a patient.
If doctors could predict ahead of time which patients are most likely to benefit from ECT, it could help more people get this potentially life-changing treatment while avoiding unnecessary side effects for those unlikely to improve. A large international study has now found that brain scans may help make these predictions possible.
Combining Brain Structure and Function Data
The study used magnetic resonance imaging (MRI) brain scans from 189 patients with severe depression across seven medical centers in Europe and North America. The researchers looked at both the structure of patients’ brains (the size and shape of different regions) as well as how different areas communicated with each other (known as functional connectivity).
Using machine learning computer algorithms, they tested whether this brain imaging data could predict which patients would achieve remission after a course of ECT. Remission means having minimal or no depression symptoms after treatment.
The best predictions came from combining structural and functional brain data. This combined approach could predict remission with about 80% accuracy when tested on patients from the same medical centers used to develop the predictive model. Importantly, it maintained 70-73% accuracy when tested on completely new patients from different medical centers not used in developing the model.
Key Brain Regions Involved
Several brain areas emerged as particularly important for predicting ECT outcomes:
The dorsomedial prefrontal cortex: This region is involved in regulating emotions and is part of brain networks that are often disrupted in depression.
The precuneus: This area is important for self-reflection and is part of the brain’s “default mode network” which is overactive in depression.
The thalamus: This region acts as a relay station and is part of circuits involved in mood regulation.
The temporal lobes: These areas, which include the hippocampus and amygdala, are involved in memory and emotion processing.
The structural and functional properties of these regions before ECT treatment helped distinguish which patients were likely to achieve remission.
Implications and Future Directions
This study provides evidence that brain scans might eventually be used to help guide ECT treatment decisions. However, larger studies are still needed before this approach could be used clinically.
If further validated, this type of predictive model could help doctors and patients make more informed choices about pursuing ECT. It could increase the overall success rate of ECT by identifying the patients most likely to benefit. This could potentially expand access to ECT for more people with severe depression.
The brain regions identified also provide insights into the biology of depression and ECT response. They highlight the importance of emotion regulation networks and areas involved in self-reflection – both of which are disrupted in depression and may be key targets for effective treatment.
Limitations and Next Steps
There are some important limitations to keep in mind:
- The study included a mix of patients on and off medications, which could affect brain patterns.
- While 189 patients is a large sample for this type of study, even larger studies will be needed to develop a robust clinical tool.
- The predictions were not perfect – they were wrong for about 20-30% of patients.
Future research should:
- Test these models in larger groups of patients
- Examine whether they work equally well for different subtypes of depression
- Compare ECT predictions to those for other treatments like antidepressants or psychotherapy
Conclusions
- Brain scans show promise for predicting ECT outcomes in severe depression
- Combining structural and functional brain data provided the best predictions
- Key brain areas involved include regions for emotion regulation and self-reflection
- Larger studies are still needed before this approach could guide clinical decisions
While more research is needed, this study takes an important step toward personalizing depression treatment. In the future, brain scans might help match patients to the treatments most likely to help them, potentially transforming care for severe depression.